Dublin, March 23, 2023 (GLOBE NEWSWIRE) -- The "Live Cell Encapsulation Market Size, Share & Trends Analysis Report By Polymer Type (Natural, Synthetic), By Application (Drug Delivery, Cell Transplantation), By Method, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global live cell encapsulation market size is projected to reach USD 286.5 million by 2030, registering a CAGR of 3.97% during the forecast period.
Increasing adoption of live cell encapsulation in regenerative medicine, rising public-private investments in cell & gene therapies, and the growing significance of live cell encapsulation for therapeutic purposes are key factors driving the industry. Furthermore, major advantages associated with live cell encapsulation of a drug or treatment system include easy administration, the possibility to control the accurate release rate of a drug over time, and the provision of desired, pre-programmed drug release anticipated to boost the industry growth over the study period. Increasing public-private funding & investments in cell and gene therapies are projected to drive the market during the forecast period.
For instance, in June 2022, Immuneel Therapeutics raised series A funding of USD 15 million to develop affordable cell and gene therapy for cancer patients in India. In October 2022, Vita Therapeutics received series B funding of USD 31 million for the development of cell therapies for neuromuscular diseases and cancers. Hence, increasing funding may boost R&D activities, ultimately increasing the demand for live cell encapsulation techniques.
Encapsulated islet cells prevent low and high sugar levels from occurring, and eliminate the need for daily blood glucose tests & take insulin daily. Hence, the growing significance of live cell encapsulation for therapeutic purposes is expected to drive the adoption of these methods. Furthermore, increasing strategic initiatives, such as partnerships and clinical trials on cell encapsulation technology, by operating players are expected to drive the industry.
Live Cell Encapsulation Market Report Highlights
- The natural polymers segment held the largest share in 2022 owing to its advantages, such as low toxicity, renewability, biocompatibility, flexibility to modification, and biodegradability
- The microencapsulation method segment accounted for the largest share in 2022 due to the benefits offered by microencapsulation, including pre-programmed drug-release profiles, easy administration, and the ability of the technique to control the release rate of a fused drug over periods (hours to months)
- The drug delivery application segment dominated the industry in 2022 owing to the potential application of drug delivery to treat various diseases, such as cancer, tuberculosis, diabetes, and rheumatoid arthritis, in the form of tablets, capsules, or parenteral dosage forms
- North America held the largest revenue share in 2022. The large share can be attributed to established healthcare infrastructure, increased per capita healthcare expenditure, and rising funding & investments in cell and gene therapies space in the region
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 150 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $210.7 Million |
| Forecasted Market Value (USD) by 2030 | $286.5 Million |
| Compound Annual Growth Rate | 3.9% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends, & Scope
Chapter 4 Polymer Type Business Analysis
4.1 Live Cell Encapsulation Market-Polymer Type Movement Analysis
4.2 Natural Polymers
4.2.2 Alginate
4.2.3 Chitosan
4.2.4 Cellulose
4.2.5 Others
4.3 Synthetic Polymers
Chapter 5 Method Business Analysis
5.1 Live Cell Encapsulation Market-Method Movement Analysis
5.2 Microencapsulation
5.3 Macroencapsulation
5.4 Nanoencapsulation
Chapter 6 Application Business Analysis
6.1 Live Cell Encapsulation Market-Application Movement Analysis
6.2 Drug Delivery
6.3 Regenerative Medicine
6.4 Cell Transplantation
6.5 Others
Chapter 7 Regional Business Analysis
Chapter 8 Competitive Landscape
Companies Mentioned
- AUSTRIANOVA
- MERCK KGAA
- SPHERE FLUIDICS LIMITED
- VIACYTE, INC.
- BLACKTRACE HOLDINGS LTD (DOLOMITE MICROFLUIDICS)
- BIO INX
- LIVING CELL TECHNOLOGIES LIMITED
- SIGILON THERAPEUTICS, INC.
- ISOGEN
- DIATRANZ OTSUKA LTD
For more information about this report visit https://www.researchandmarkets.com/r/a2iozc
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
